Autopsy report · NCT00354432
Soy Protein/Effexor Hormone Therapy for Prostate Cancer
Cause of deathFutility
“Stopped by the DSMB for lack of effect per interim stopping rule.”
Life of this trial
- Registered 6 months before it started.
- Ran for about 3 years 6 months before it stopped.
- 120 participants enrolled.
- Results were posted on the registry 6 years 10 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Wake Forest University Health Sciences
- Sponsor type
- University, hospital or other
- Conditions
- Hot Flashes; Prostate Cancer
- Interventions
- oral soy protein/isoflavones powder; Venlafaxine; Placebo Powder; Placebo Pill
- Participants
- 120
- Sites
- 20
- Countries
- United States
Trials that died the same way
- Testing Pharmacological Therapies for Pregnant Smokers
“was terminated due to meeting a priori stopping rule set by DSMB” - AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
“The DSMB halted the trial prematurely due to futility without any safety concerns.” - Randomized Trial of Primary Surgery Followed Selective Radiochemotherapy for Rectal Cancer With MRI Negative CRM
“DSMB stopped this trial due to the difference of 3-year DFS's rate between two groups more than 5% at the interim analysis in July 2021.” - Helping HIV Infected Patients in South Africa Adhere to Drug Regimens
“DSMB stopped trial for futility” - Estrogen Replacement to Reduce Risk of Neurologic Injury After Coronary Artery Bypass Graft Surgery
“DSMB stopped the study based on conclusion of likely futility of treatment on the primary outcome.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.